Department of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Department of Neurosurgery, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Pathol Oncol Res. 2024 Aug 6;30:1611730. doi: 10.3389/pore.2024.1611730. eCollection 2024.
Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma that occurs at widespread anatomical locations, such as bone, soft tissue, and intracranial sites. The central nervous system (CNS) is one of the most common origins of extraosseous MCS. However, alternative fusions have not been reported in this tumor.
We report a case of intracranial MCS with rearrangement. A 52-year-old woman presented with a 15-mm calcified mass around the sella turcica. She initially underwent transsphenoidal surgery for tumor resection and then additional resections for five local recurrences over 5 years. Histologically, the tumor was composed of small round to spindle-shaped cells admixed with well-differentiated hyaline cartilaginous islands. A hemangiopericytoma-like vascular pattern and small sinusoid-like vessels were also observed. RNA sequencing using RNA extracted from formalin-fixed paraffin-embedded samples from the last operation revealed two alternative variants of the fusion: (ex4):: (ex13) and (ex4)::(ex14). Both variants were confirmed as in-frame fusions using reverse transcription-polymerase chain reaction.
Cartilaginous components were often not apparent during the recurrences. In addition to the non-typical pathological finding, the correct diagnosis was hampered by the poor RNA quality of the surgical specimens and non-specific STAT6 nuclear staining.
This is the first reported case of intracranial MCS with an alternative fusion.
间叶性软骨肉瘤(MCS)是一种罕见的软骨肉瘤亚型,发生于广泛的解剖部位,如骨、软组织和颅内部位。中枢神经系统(CNS)是颅外 MCS 最常见的起源之一。然而,在这种肿瘤中尚未报道过其他融合。
我们报告了一例伴有重排的颅内 MCS 病例。一名 52 岁女性因蝶鞍周围 15mm 钙化肿块就诊。她最初接受了经蝶窦手术进行肿瘤切除,然后在 5 年内因 5 次局部复发进行了额外的切除。组织学上,肿瘤由小圆形到梭形细胞与分化良好的透明软骨岛混合而成。还观察到血管外皮细胞瘤样血管模式和小窦状血管。使用从最后一次手术的福尔马林固定石蜡包埋样本中提取的 RNA 进行 RNA 测序显示了 融合的两种替代变体:(ex4)::(ex13)和(ex4)::(ex14)。两种变体均通过逆转录-聚合酶链反应证实为框内融合。
在复发过程中,软骨成分通常不明显。除了非典型的病理发现外,由于手术标本的 RNA 质量差和 STAT6 核染色非特异性,正确的诊断也受到阻碍。
这是首例报道的伴有替代 融合的颅内 MCS 病例。